Australia markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0580-0.0010 (-1.69%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 119.36M
Enterprise value 95.87M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.87
Price/book (mrq)2.93
Enterprise value/revenue 9.54
Enterprise value/EBITDA -9.34

Trading information

Stock price history

Beta (5Y monthly) 2.86
52-week change 3-61.94%
S&P500 52-week change 332.30%
52-week high 30.1650
52-week low 30.0420
50-day moving average 30.0546
200-day moving average 30.0825

Share statistics

Avg vol (3-month) 32.2M
Avg vol (10-day) 31.64M
Shares outstanding 52.02B
Implied shares outstanding 62.09B
Float 81.79B
% held by insiders 18.98%
% held by institutions 116.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2024
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -191.78%
Operating margin (ttm)-200.92%

Management effectiveness

Return on assets (ttm)-25.96%
Return on equity (ttm)-38.95%

Income statement

Revenue (ttm)10.32M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-2.70%
Gross profit (ttm)N/A
EBITDA -23.46M
Net income avi to common (ttm)-19.79M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.63M
Total cash per share (mrq)0.01
Total debt (mrq)1.14M
Total debt/equity (mrq)2.80%
Current ratio (mrq)6.33
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-17.79M
Levered free cash flow (ttm)-16.44M